This included demographic and baseline characteristics, dose and duration of nebulized anticoagulants, duration of ventilation, occurrence of pneumonia, length of stay in the ICU and hospital, and mortality.
A model-based meta-analysis (MBMA) is a type of meta-regression that uses nonlinear mixed-effects models estimated on trial-level data to relate patient and trial characteristics, dosing, biomarkers, and outcomes of treatment.
However, in addition to heart rate and acquisition-related confounders, isolated post-contrast T1 values are influenced by a number of factors, including body fat percentage, reduced renal function, altered haematocrit, native T1, delay time in measurement after contrast administration and gadolinium characteristics (dose, concentration and water exchange rate).
As the ADVANTAGE™ I-125, Model IAI-125 source is commercially available for interstitial brachytherapy treatment, dosimetric characteristics (dose rate constant, radial dose function and anisotropy function) of this source were theoretically determined following the updated AAPM task group 43 (TG-43U1) recommendations.
Table 1 summarises the patient characteristics, dosing information and potential covariates used in the analysis.
Known influential factors on adherence in IBD include socio-demographic characteristics, dosing, depression, disease awareness, the therapeutic relationship, disease activity and psychosocial characteristics [ 1, 5- 11].
To our knowledge, no previous study has evaluated the clinical use of quetiapine XR and IR with respect to, for instance, patient characteristics, dosing and add-on medication.
Data extracted included study details, inclusion and exclusion criteria, baseline patient characteristics, dose, follow-up, change in best corrected visual acuity, and change in central macular thickness.
Chart data provided information on patient characteristics, dosing regimens, and glycemic profiles as well as other pharmacological treatments and clinical outcomes not captured in the MDS.
One of the strengths of this study was that chart data were used to provide information on patient characteristics, dosing regimens, and glycemic profiles, as well as other pharmacological treatments and clinical outcomes not captured in the MDS.
